Semaglutide Compounding Safety Concerns: 10 Deaths Reported
Semaglutide, a drug widely used for the management of type 2 diabetes and weight loss, has been linked to a concerning rise in fatalities, prompting a warning from the CEO of Novo Nordisk, the drug’s manufacturer.